The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Structure of Human Methionine Aminopeptidase-2 Complexed with Fumagillin
Abstract
The fungal metabolite fumagillin suppresses the formation of new blood vessels, and a fumagillin analog is currently in clinical trials as an anticancer agent. The molecular target of fumagillin is methionine aminopeptidase-2 (MetAP-2). A 1.8 Å resolution crystal structure of free and inhibited human MetAP-2 shows a covalent bond formed between a reactive epoxide of fumagillin and histidine-231 in the active site of MetAP-2. Extensive hydrophobic and water-mediated polar interactions with other parts of fumagillin provide additional affinity. Fumagillin-based drugs inhibit MetAP-2 but not MetAP-1, and the three-dimensional structure also indicates the likely determinants of this specificity. The structural basis for fumagillin's potency and specificity forms the starting point for structure-based drug design.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These nucleophilic centers are also present in DNA and other biologically relevant compounds, such as glutathione.116–121”
From Connecting metabolome and phenotype: recent advances in functional metabolomics tools for the identification of bioactive natural products (2024) · cites this paper as [118]
Citations
Cites
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,796
MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures
Kraulis, P. J. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891004399 · Cited by 14,011
Jones, T. A., Zou, J.-Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,616
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions
Wallace, A. C., Laskowski, R. A., & Thornton, J. M. (1995) · Protein Engineering Design and Selection · doi:10.1093/protein/8.2.127 · Cited by 5,731
AMoRe: an automated package for molecular replacement
Navaza, J. (1994) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767393007597 · Cited by 4,941
Crystallographic R Factor Refinement by Molecular Dynamics
Brünger, A. T., Kuriyan, J., & Karplus, M. (1987) · Science · doi:10.1126/science.235.4787.458 · Cited by 1,950
Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth
Ingber, D. E., Fujita, T., KISHIMOTO, S., Sudo, K., KANAMARU, T., Brem, H., & Folkman, J. (1990) · Nature · doi:10.1038/348555a0 · Cited by 1,301
Serine Proteases: Structure and Mechanism of Catalysis
Kraut, J. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.001555 · Cited by 1,253
ALSCRIPT: a tool to format multiple sequence alignments
Barton, G. J. (1993) · Protein Engineering Design and Selection · doi:10.1093/protein/6.1.37 · Cited by 1,144
Research works printed but not linked: 1
- J. Wang N. Quan J. Henkin Proc. Am. Assoc. Cancer Res. 39 98 (abstr.) (1998).
Cited by
Sorted by citations
Items 101–200 of 455
Chen, X., Xie, S., Bhat, S., Kumar, N., Shapiro, T. A., & Liu, J. O. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.01.006 · Cited by 59
Covalent drugs targeting histidine – an unexploited opportunity?
Che, J., & Jones, L. H. (2022) · RSC Medicinal Chemistry · doi:10.1039/d2md00258b · Cited by 58
Hot Spot Analysis for Driving the Development of Hits into Leads in Fragment-Based Drug Discovery
Hall, D. R., Ngan, C. H., Zerbe, B. S., Kozakov, D., & Vajda, S. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci200468p · Cited by 58
Han, C. K., Ahn, S. K., Choi, N. S., Hong, R. K., Moon, S. K., Chun, H. S., Lee, S. J., Kim, J. W., Hong, C. I., Kim, D., et al. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00577-6 · Cited by 58
A New Approach to the Inhibition of Metallo‐β‐lactamases
SPENCER, J. M., & Walsh, T. R. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200502984 · Cited by 57
Covalent modification as a strategy to block protein–protein interactions with small-molecule drugs
Way, J. (2000) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(99)00049-6 · Cited by 55
Epoxides: Developability as active pharmaceutical ingredients and biochemical probes
Kaur, B., & Singh, P. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.105862 · Cited by 57
NAC controls cotranslational N-terminal methionine excision in eukaryotes
Gamerdinger, M., Jia, M. Z., Schlömer, R., Rabl, L., Jaskółowski, M., Khakzar, K. M., Ulusoy, Z., Wallisch, A., Jomaa, A., Hunaeus, G., et al. (2023) · Science · doi:10.1126/science.adg3297 · Cited by 54
FE(II) Is the Native Cofactor for Escherichia coli Methionine Aminopeptidase
Chai, S. C., Wang, W.-L., & Ye, Q.-Z. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804345200 · Cited by 55
Zhang, R., Pan, D., Cai, X., Yang, X., Senpan, A., Allen, J. S., Lanza, G. M., & Wang, L. V. (2014) · Theranostics · doi:10.7150/thno.10014 · Cited by 56
MAPs and POEP of the roads from prokaryotic to eukaryotic kingdoms
Datta, B. (2000) · Biochimie · doi:10.1016/s0300-9084(00)00383-7 · Cited by 55
Zhang, X., Wang, T. T., Xu, Q. L., Xiong, Y., Zhang, L., Han, H., Xu, K., Guo, W. J., Xu, Q., Tan, R. X., et al. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201804317 · Cited by 54
Taber, D. F., Christos, T. E., Rheingold, A. L., & Guzei, I. A. (1999) · Journal of the American Chemical Society · doi:10.1021/ja990784k · Cited by 54
Anticancer fungal natural products: Mechanisms of action and biosynthesis
Yuan, S., Gopal, J. V., Ren, S., Chen, L., Liu, L., & Gao, Z. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112502 · Cited by 54
Structural basis of catalysis by monometalated methionine aminopeptidase
Ye, Q.-Z., Xie, S.-X., Ma, Z.-Q., Huang, M., & Hanzlik, R. P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602433103 · Cited by 52
The relationship between the cyclic-RGDfK ligand and αvβ3 integrin receptor
Mondal, G., Barui, S., & Chaudhuri, A. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.04.065 · Cited by 52
Ligerin, an Antiproliferative Chlorinated Sesquiterpenoid from a Marine-Derived Penicillium Strain
Vansteelandt, M., Blanchet, É., Egorov, M., Petit, F., TOUPET, L. J., Bondon, A., Monteau, F., Bizec, B. L., Thomas, O., Pouchus, Y. F., et al. (2013) · Journal of Natural Products · doi:10.1021/np3007364 · Cited by 52
Specificity for inhibitors of metal-substituted methionine aminopeptidase
Li, J.-Y., Chen, L., Cui, Y.-M., Luo, Q., Li, J. X., Nan, F.-J., & Ye, Q.-Z. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01144-6 · Cited by 52
Klohs, W. D., & Hamby, J. M. (1999) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(99)00033-6 · Cited by 51
Tucker, L. A., Zhang, Q., Sheppard, G. S., Lou, P., Jiang, F., McKeegan, E. M., Lesniewski, R., Davidsen, S. K., Bell, R. L., & Wang, J. (2008) · Oncogene · doi:10.1038/onc.2008.14 · Cited by 51
Depletion of Methionine Aminopeptidase 2 Does Not Alter Cell Response to Fumagillin or Bengamides
Kim, S., LaMontagne, K. R., Sabio, M. L., Sharma, S. K., Versace, R. W., Yusuff, N., & Phillips, P. E. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0019 · Cited by 51
Fumagillin Reduces Adipose Tissue Formation in Murine Models of Nutritionally Induced Obesity
Lijnen, H. R., Frederix, L., & HOEF, B. V. (2010) · Obesity · doi:10.1038/oby.2009.503 · Cited by 48
Evans, M. J., Morris, G. M., Wu, J., Olson, A. J., Sorensen, E. J., & Cravatt, B. F. (2007) · Molecular BioSystems · doi:10.1039/b705113a · Cited by 48
Evaluation of genotoxic effects of fumagillin by cytogenetic tests in vivo
Stanimirović, Z., Stevanović, J., Bajić, V., & Radović, I. (2007) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2006.09.014 · Cited by 48
Two Continuous Spectrophotometric Assays for Methionine Aminopeptidase
Zhou, Y., Guo, X., Tian, Y., Yoshimoto, T., & Pei, D. (2000) · Analytical Biochemistry · doi:10.1006/abio.2000.4513 · Cited by 48
Bompard, C., Villeret, V., Davies, G. J., Fanuel, L., Joris, B., Frère, J., & BEEUMEN, J. V. (2000) · Structure · doi:10.1016/s0969-2126(00)00091-5 · Cited by 47
Garrabrant, T. A., Tuman, R. W., Ludovici, D. W., Tominovich, R. M., Simoneaux, R., & Galemmo, R. A. (2004) · Angiogenesis · doi:10.1007/s10456-004-6089-7 · Cited by 47
Douangamath, A., Dale, G. E., D'Arcy, A., Almstetter, M., Eckl, R. W., Frutos-Hoener, A., Henkel, B., Illgen, K., Nerdinger, S., Schulz, H., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm034188j · Cited by 47
Brown, D. A., GLASS, W. K., Fitzpatrick, N. J., Kemp, T. J., Errington, W., Clarkson, G. J., Haase, W., Karsten, F., & Mahdy, A. H. (2003) · Inorganica Chimica Acta · doi:10.1016/j.ica.2003.08.021 · Cited by 45
Frottin, F., Bienvenut, W. V., Bignon, J. S., Jacquet, E., Jácome, A. S. V., DORSSELAER, A. V., Cianférani, S., Carapito, C., Meinnel, T., & Giglione, C. (2016) · Oncotarget · doi:10.18632/oncotarget.11216 · Cited by 47
Targeting methionine aminopeptidase 2 in cancer, obesity, and autoimmunity
Grocin, A. G., Kallemeijn, W. W., & Tate, E. W. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.07.004 · Cited by 45
Datta, B., Majumdar, A., Datta, R., & Balusu, R. (2004) · Biochemistry · doi:10.1021/bi049172p · Cited by 45
Kanno, T., Endo, H., Takeuchi, K., Morishita, Y., Fukayama, M., & Mori, S. (2002) · Laboratory Investigation · doi:10.1097/01.lab.0000020419.25365.c4 · Cited by 44
Covalent binders in drug discovery
Vasudevan, A., Argiriadi, M. A., Baranczak, A., Friedman, M., Gavrilyuk, J. I., Hobson, A. D., Hulce, J. J., Osman, S., & Wilson, N. S. (2019) · Progress in medicinal chemistry · doi:10.1016/bs.pmch.2018.12.002 · Cited by 43
Antiangiogenic Agents: Studies on Fumagillin and Curcumin Analogs
Furness, M. S., Robinson, T., Ehlers, T., Hubbard, R., Arbiser, J. L., Goldsmith, D. J., & Bowena, J. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053382142 · Cited by 43
Natural Products in Drug Discovery: Impacts and Opportunities — An Assessment
Brahmachari, G. (2011) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814335386_0001 · Cited by 45
Fungal metabolites: structural diversity as incentive for anticancer drug development
Greve, H., Mohamed, I. E.-T., Pontius, A., Kehraus, S., Gross, H., & König, G. M. (2010) · Phytochemistry Reviews · doi:10.1007/s11101-010-9198-5 · Cited by 41
van den Heever, J. P., Thompson, T. S., Otto, S. J. G., Curtis, J. M., Ibrahim, A. A., & Pernal, S. F. (2015) · Apidologie · doi:10.1007/s13592-015-0409-3 · Cited by 40
3-Amino-2-hydroxyamides and related compounds as inhibitors of methionine aminopeptidase-2
Sheppard, G. S., Wang, J., Kawai, M., BaMaung, N. Y., Craig, R. A., Erickson, S. A., Lynch, L., Patel, J. R., Yang, F., Searle, X. B., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.12.031 · Cited by 40
Mauriz, J. L., Martín‐Renedo, J., Palomo, A. G., Tuñón, M. J., & González‐Gallego, J. (2010) · Current Drug Targets · doi:10.2174/1389450111009011439 · Cited by 40
Chemistry and Biology of Bengamides and Bengazoles, Bioactive Natural Products from Jaspis Sponges
García‐Ruiz, C., & Sarabia, F. (2014) · Marine Drugs · doi:10.3390/md12031580 · Cited by 39
Cutforth, T., & Gaul, U. (1999) · Mechanisms of Development · doi:10.1016/s0925-4773(99)00006-4 · Cited by 39
Discovery of Novel Antigiardiasis Drug Candidates
Kulakova, L., Galkin, A. G., Chen, C. Z., Southall, N. T., Marugán, J., Zheng, W., & Herzberg, O. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03834-14 · Cited by 38
Local inhibition of angiogenesis results in an atrophic non-union in a rat osteotomy model
Fassbender, M., Strobel, C., Rauhe, J., Bergmann, C., Schmidmaier, G., & Wildemann, B. (2011) · European Cells and Materials · doi:10.22203/ecm.v022a01 · Cited by 38
Identification of Protein Fold Topology Shared between Different Folds Inhibited by Natural Products
McArdle, B. M., & Quinn, R. J. (2007) · ChemBioChem · doi:10.1002/cbic.200700035 · Cited by 38
Morgen, M., Jöst, C., Malz, M., Janowski, R., Niessing, D., Klein, C. D. P., Gunkel, N., & Miller, A. K. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00755 · Cited by 38
Substrate specificity and reaction mechanism of human prolidase
Wilk, P., Ühlein, M., Kalms, J., Dobbek, H., Müeller, U., & Weiss, M. S. (2017) · FEBS Journal · doi:10.1111/febs.14158 · Cited by 38
Substituted oxines inhibit endothelial cell proliferation and angiogenesis
Bhat, S., Shim, J. S., Zhang, F., Chong, C. R., & Liu, J. O. (2012) · Organic & Biomolecular Chemistry · doi:10.1039/c2ob06978d · Cited by 37
Magistrato, A., DeGrado, W. F., Laio, A., Röthlisberger, U., VandeVondele, J., & Klein, M. L. (2003) · The Journal of Physical Chemistry B · doi:10.1021/jp027032o · Cited by 37
Datta, R., Choudhury, P., Bhattacharya, M., Leon, F. S., Zhou, Y. L., & Datta, B. (2001) · Biochimie · doi:10.1016/s0300-9084(01)01344-x · Cited by 37
Wang, J., Tucker, L. A., Stavropoulos, J. A., Zhang, Q., Wang, Y., Bukofzer, G. T., Niquette, A. L., Meulbroek, J. A., Barnes, D. M., Shen, J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708766105 · Cited by 37
Zhang, H., Huang, H., Cali, A., Takvorian, P. M., Feng, X., Zhou, G., & Weiss, L. M. (2005) · Folia Parasitologica · doi:10.14411/fp.2005.023 · Cited by 37
Nanomedicine Opportunities in Cardiology
Lanza, G. M., Winter, P. M., Cyrus, T., Caruthers, S. D., Marsh, J. N., Hughes, M. S., & Wickline, S. A. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1380.034 · Cited by 36
Fumagillin: an anti-infective as a parent molecule for novel angiogenesis inhibitors
Lefkove, B., Govindarajan, B., & Arbiser, J. L. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.4.573 · Cited by 36
Catalytic mechanisms for metallopeptidases
Auld, D. S. (2004) · Elsevier eBooks · doi:10.1016/b978-0-12-079611-3.50076-8 · Cited by 37
Nakagawa, H., Koyanagi, S., Takiguchi, T., Kuramoto, Y., Soeda, S., Shimeno, H., Higuchi, S., & Ohdo, S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2122 · Cited by 35
Bennett, B., Antholine, W. E., D’souza, V. M., Chen, G., Ustinyuk, L., & Holz, R. C. (2002) · Journal of the American Chemical Society · doi:10.1021/ja026341p · Cited by 34
DRAHL, C., Cravatt, B. F., & Sorensen, E. J. (2005) · Angewandte Chemie · doi:10.1002/ange.200500900 · Cited by 34
Structure of a microsporidian methionine aminopeptidase type 2 complexed with fumagillin and TNP-470
Alvarado, J. J., Nemkal, A., Sauder, J. M., Russell, M., Akiyoshi, D. E., Shi, W., Almo, S. C., & Weiss, L. M. (2009) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2009.07.008 · Cited by 34
Methionine aminopeptidase 2 inhibition: antiangiogenesis and tumour therapy
Bradshaw, R. A. (2004) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.14.1.1 · Cited by 34
Natural products: chemical instruments to apprehend biological symphony
Pucheault, M. (2007) · Organic & Biomolecular Chemistry · doi:10.1039/b713022h · Cited by 34
Peptidyl hydroxamic acids as methionine aminopeptidase inhibitors
Hu, X., Zhu, J. G., Srivathsan, S., & Pei, D. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.10.031 · Cited by 33
Yoshizawa, M., Itoh, T., Hori, T., Kato, A., Anami, Y., Yoshimoto, N., & Yamamoto, K. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00774 · Cited by 32
Antiangiogenic Nanotherapy with Lipase-Labile Sn-2 Fumagillin Prodrug
Pan, D., Sanyal, N., Schmieder, A. H., Senpan, A., Kim, B. B., Yang, X., Hu, G., Allen, J. S., Gross, R. W., Wickline, S. A., et al. (2012) · Nanomedicine · doi:10.2217/nnm.12.27 · Cited by 32
Using model-system genetics for drug-based target discovery
Matthews, D. J., & Kopczynski, J. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(00)01612-3 · Cited by 32
A Stereoselective Formal Synthesis of (−)‐Fumagillol
Bedel, O., Haudrechy, A., & Langlois, Y. (2004) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200400262 · Cited by 32
Peyret, P., Katinka, M. D., Duprat, S., Duffieux, F., Barbe, V., Barbazanges, M., Weissenbach, J., Saurin, W., & Vivarès, C. P. (2001) · Genome Research · doi:10.1101/gr.164301 · Cited by 32
First total synthesis of (±)-AM6898A and (±)-AM6898D
Fukuda, Y., & Okamoto, Y. (2002) · Tetrahedron · doi:10.1016/s0040-4020(02)00155-2 · Cited by 31
Heinrich, T., Seenisamy, J., Blume, B., Bomke, J., Calderini, M., Eckert, U., Friese‐Hamim, M., Kohl, R., Lehmann, M., Leuthner, B., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00041 · Cited by 30
Fast and efficient synthesis of novel fumagillin analogues
Baldwin, J. E., Bulger, P. G., & Márquez, R. (2002) · Tetrahedron · doi:10.1016/s0040-4020(02)00514-8 · Cited by 30
Du, X., Tove, S. R., Kast-Hutcheson, K., & Grunden, A. M. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.09.086 · Cited by 29
Carbamate Analogues of Fumagillin as Potent, Targeted Inhibitors of Methionine Aminopeptidase-2
Arico-Muendel, C. C., Benjamin, D. R., Caiazzo, T., Centrella, P. A., Contonio, B. D., Cook, C. M., Doyle, E., Hannig, G., Labenski, M., Searle, L. L., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901260k · Cited by 29
Cobalt and Corrinoid Transport and Biochemistry
Cracan, V., & Banerjee, R. V. (2012) · Metal ions in life sciences · doi:10.1007/978-94-007-5561-1_10 · Cited by 30
Casanova, I., Durán, M. L., Viqueira, J., Sousa‐Pedrares, A., Zani, F., Real, J. A., & García-Vázquez, J. A. (2018) · Dalton Transactions · doi:10.1039/c8dt00532j · Cited by 29
Design of next-generation covalent inhibitors: Targeting residues beyond cysteine
Jones, L. H. (2020) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2020.10.001 · Cited by 28
Redox Regulation of Methionine Aminopeptidase 2 Activity
Chiu, J., Wong, J. W. H., & Hogg, P. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.554253 · Cited by 28
Hannig, G., Bernier, S. G., Hoyt, J. G., Doyle, B., Clark, E., Karp, R., Lorusso, J., & Westlin, W. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22402 · Cited by 28
The C. elegans methionine aminopeptidase 2 analog map‐2 is required for germ cell proliferation
Boxem, M., Tsai, C. W., Zhang, Y., Saito, R. M., & Liu, J. O. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.08.077 · Cited by 28
Aminopeptidases and Angiogenesis
Sato, Y. (2003) · Endothelium · doi:10.1080/10623320390272334 · Cited by 28
The two authentic methionine aminopeptidase genes are differentially expressed in Bacillus subtilis
You, C., Lu, H., Sekowska, A., Fang, G., Wang, Y., Gilles, A., & Danchin, A. (2005) · BMC Microbiology · doi:10.1186/1471-2180-5-57 · Cited by 28
Roles of P67/MetAP2 as a tumor suppressor
Datta, B. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.08.002 · Cited by 27
Bhat, S. Y., Jagruthi, P., Angapelly, S., Arifuddin, M., & Qureshi, I. A. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111860 · Cited by 27
Li, J.-Y., Cui, Y.-M., Chen, L., Gu, M., Li, J. X., Nan, F.-J., & Ye, Q.-Z. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401679200 · Cited by 27
Concise stereocontrolled routes to fumagillol, fumagillin, and TNP‐470
Vosburg, D. A., Weiler, S., & Sorensen, E. J. (2003) · Chirality · doi:10.1002/chir.10181 · Cited by 27
Jiang, M., Wu, Z., Wu, Q., Yin, H., Guo, H., Yuan, S., Liu, Z., Chen, S., & Liu, L. (2021) · Chinese Chemical Letters · doi:10.1016/j.cclet.2021.01.027 · Cited by 26
Antiparasitic activities of novel, orally available fumagillin analogs
Arico-Muendel, C. C., Contonio, B. D., Morgan, B. A., O’Donovan, G. K., Paradise, C. L., Skinner, S. R., SLUBOSKI, B. C., Svendsen, J. L., White, K., Debnath, A., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.07.029 · Cited by 26
Magnetic Drug Targeting in Partly Occluded Blood Vessels Using Magnetic Microspheres
Banerjee, M. K., Datta, A., & Ganguly, R. (2010) · Journal of Nanotechnology in Engineering and Medicine · doi:10.1115/1.4002418 · Cited by 26
Epi-, Epoxy-, and C2-Modified Bengamides: Synthesis and Biological Evaluation
Sarabia, F., Martín‐Gálvez, F., García‐Ruiz, C., Sánchez‐Ruiz, A., & Vivar‐García, C. (2013) · The Journal of Organic Chemistry · doi:10.1021/jo4003272 · Cited by 26
Brdlik, C. M., & Crews, C. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307246200 · Cited by 26
Self-citationCombined Biophysical Chemistry Reveals a New Covalent Inhibitor with a Low-Reactivity Alkyl Halide
Li, T., Maltais, R., Poirier, D., & Lin, S. (2018) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.8b02225 · Cited by 25
Asami, Y., Kakeya, H., Onose, R., Chang, Y., Toi, M., & Osada, H. (2004) · Tetrahedron · doi:10.1016/j.tet.2003.09.104 · Cited by 25
Addlagatta, A., & Matthews, B. W. (2006) · Protein Science · doi:10.1110/ps.062278006 · Cited by 25
Jin, C., Nagasawa, H., Shimamura, M., Uto, Y., Inayama, S., Takéuchi, Y., Kirk, K. L., & Hori, H. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.06.039 · Cited by 25
Copik, A. J., Nocek, B. P., Swierczek, S. I., Ruebush, S. S., Jang, S. B., Meng, L., D’souza, V. M., Peters, J. W., Bennett, B., & Holz, R. C. (2004) · Biochemistry · doi:10.1021/bi048123+ · Cited by 25
Zhao, H., Zou, J., Xü, W., Hu, D., Guo, L., Chen, J., Chen, G., So, K., Yao, X., & Gao, H. (2021) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.1c00369 · Cited by 24
Hong, X., Guan, X., Lai, Q., Yu, D., Chen, Z., Fu, X.-T., Zhang, B., Chen, C., Shao, Z., Xia, J., et al. (2022) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-022-11914-1 · Cited by 24
Metal mediated inhibition of methionine aminopeptidase by quinolinyl sulfonamides
Huang, M., Xie, S.-X., Ma, Z.-Q., Hanzlik, R. P., & Ye, Q.-Z. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.11.042 · Cited by 24
Warder, S. E., Tucker, L. A., McLoughlin, S. M., Strelitzer, T. J., Meuth, J. L., Zhang, Q., Sheppard, G. S., Richardson, P. L., Lesniewski, R., Davidsen, S. K., et al. (2008) · Journal of Proteome Research · doi:10.1021/pr800388p · Cited by 24
Lanza, G. M., Jenkins, J., Schmieder, A. H., Moldobaeva, A., Cui, G., Zhang, H., Yang, X., Zhong, Q., Keupp, J., Sergin, I., et al. (2016) · Theranostics · doi:10.7150/thno.16627 · Cited by 24
Synthesis of the Furanosteroidal Antibiotic Viridin
Anderson, E. A., Alexanian, E. J., & Sorensen, E. J. (2004) · Angewandte Chemie · doi:10.1002/ange.200353129 · Cited by 24
Metadata
- Authors
- Liu, S., Widom, J., Kemp, C. W., Crews, C. M., & Clardy, J.
- Affiliations
- Cornell University (US)
- Corresponding author
- Clardy, Jon
- Venue
- Science
- Published
- 1998-11-13
- Volume
- 282
- Issue
- 5392
- Pages
- 1324-1327
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2085785716
- Cited by
- 440
- References
- 28
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 14 · 2023: 14 · 2022: 12 · 2021: 13 · 2020: 13 · 2019: 13 · 2018: 13 · 2017: 5 · 2016: 10 · 2015: 14 · 2014: 14 · 2013: 16 · 2012: 13
- FWCI
- 13.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R01CA024487, CA 59021, R01CA059021, CA-24487)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Peptidase Inhibition and Analysis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- methionine aminopeptidase 2, fumagillin, crystal structure, enzyme-inhibitor complex, antivascular agents, anticancer agents, enzyme specificity, structure-based drug design
- MeSH terms
- Amino Acid Sequence, Aminopeptidases, Binding Sites, Cyclohexanes, Fatty Acids, Unsaturated, Humans, Hydrogen Bonding, Metalloendopeptidases, Models, Molecular, Molecular Sequence Data, Protein Conformation, Sesquiterpenes, Sequence Alignment, Protein Structure, Secondary, Crystallography, X-Ray
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review